DE3144455C2 - - Google Patents
Info
- Publication number
- DE3144455C2 DE3144455C2 DE3144455A DE3144455A DE3144455C2 DE 3144455 C2 DE3144455 C2 DE 3144455C2 DE 3144455 A DE3144455 A DE 3144455A DE 3144455 A DE3144455 A DE 3144455A DE 3144455 C2 DE3144455 C2 DE 3144455C2
- Authority
- DE
- Germany
- Prior art keywords
- group
- compound
- oxo
- methyl
- benzo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
Description
9-Fluoro-8-(4-hydroxy-1-piperidyl)- 5-methyl-6,7-dihydro-1-oxo-1H,5H- benzo[ÿ]chinolizin-2-karbonsäure
9-Fluoro-8-morpholino-5-methyl- 6,7-dihydro-1-oxo-1H,5H-benzo[ÿ] chinolizin-2-karbonsäure
9-Fluoro-8-(4-acetyloxy-1-piperidyl)- 5-methyl-6,7-dihydro-1-oxo-1H,5H- benzo[ÿ]chinolizin-2-karbonsäure
9-Fluoro-8-(1-piperidyl)-5-methyl- 6,7-dihydro-1-oxo-1H,5H-benzo[ÿ] chinolizin-2-karbonsäure
9-Fluoro-8-(4-dimethylamino-1-piperidyl)- 5-methyl-6,7-dihydro-1-oxo- 1H,5H-benzo[ÿ]chinolizin-2-karbonsäure
1-Ethyl-1,4-dihydro-7-methyl-4-oxo- 1,8-naphthyridin-3-karbonsäure
- A. 8-(1-Piperazinyl)-5-methyl-6,7-dihydro-1-oxo-1H,5H- benzo[ÿ]chinolizin-2-karbonsäure-hydrochlorid
- B. 8-(1-Piperazinyl)-6,7-dihydro-1-oxo-1H,5H-benzo[ÿ] chinolizin-2-karbonsäure-hydrochlorid
- C. 9-(1-Piperazinyl)-2-methyl-6-oxo-1,2-dihydro-6H-pyrrolo- [3,2,1-ÿ]chinolin-5-karbonsäure-hydrochlorid
- D. 8-(4-Methyl-1-piperazinyl)-9-fluoro-5-methyl-6,7-dihydro- 1-oxo-1H,5H-benzo[ÿ]chinolizin-2-karbonsäure
- E. 8-(1-Piperazinyl)-9-fluoro-5-methyl-6,7-dihydro-1-oxo- 1H,5H-benzo[ÿ]chinolizin-2-karbonsäure
- F. 8-Fluoro-9-(4-methyl-1-piperazinyl)-2-methyl-6-oxo-1,2- dihydro-6H-pyrrolo[3,2,1-ÿ]chinolin-5-karbonsäure
- G. 8-[4-(2-Trifluorethyl)-1-piperazinyl]-9-chlor-5- methyl-6,7-dihydro-1-oxo-1H,5H-benzo[ÿ]chinolizin- 2-karbonsäure
Testverbindung | |
ED₅₀ (mg/kg) | |
1 | |
1,84 | |
D | 3,8 |
R¹, R² die vorher angegebenen Bedeutungen haben und
X¹ ein Halogenatom, eine Niedrigalkansulfonyloxygruppe oder eine Arylsulfonyloxygruppe bedeutet, mit einer Verbindung der allgemeinen Formel (III)
R¹, R² und R³ die in Anspruch 1 angegebenen Bedeutungen haben,
R¹¹ und R¹² jeweils ein Wasserstoffatom oder eine C₁-C₆-Alkylgruppe ist,
Y einen aromatischen heterozyklischen Ring, enthaltend ein tertiäres Stickstoffatom, über welches es gebunden ist, oder eine Alkylaminogruppe bedeutet, und
Z ein Anion ist, hydrolysieren.
Berechnet (%): C 63,32, H 5,87, N 7,78;
Gefunden (%): C 63,28, H 5,76, N 7,89.
Berechnet (%): C 67,02, H 6,47, N 7,82;
Gefunden (%): C 66,93, H 6,41, N 7,91.
Berechnet (%): C 66,26, H 6,15, N 8,14;
Gefunden (%): C 66,31, H 6,02, N 8,23.
Berechnet (%): C 64,16, H 6,19, N 7,48;
Gefunden (%): C 64,01, H 6,23, N 7,31.
Berechnet (%): C 62,67, H 5,76, N 6,96;
Gefunden (%): C 62,53, H 5,87, N 6,87.
Berechnet (%): C 62,42, H 5,53, N 8,09;
Gefunden (%): C 62,25, H 5,68, N 8,03.
Berechnet (%): C 63,24, H 5,87, N 7,76;
Gefunden (%): C 63,12, H 5,95, N 7,68.
Berechnet (%): C 65,10, H 6,76, N 10,85;
Gefunden (%): C 64,97, H 6,88, N 10,72.
Berechnet (%): C 62,83, H 6,03, N 10,47;
Gefunden (%): C 62,78, H 6,15, N 10,42.
Berechnet (%): C 57,65, H 5,86, N 10,61;
Gefunden (%): C 57,46, H 5,97, N 10,52.
Berechnet (%): C 63,68, H 5,34, N 7,82;
Gefunden (%): C 63,62, H 5,45, N 7,73.
Berechnet (%): C 67,72, H 6,77, N 7,52;
Gefunden (%): C 67,68, H 6,82, N 7,48.
Berechnet (%): C 59,59, H 5,28, N 7,72;
Gefunden (%): C 59,53, H 5,35, N 7,61.
Berechnet (%): C 63,15, H 6,50, N 6,70;
Gefunden (%): C 63,28, H 6,63, N 6,57.
Berechnet (%): C 63,32, H 5,87, N 7,78;
Gefunden (%): C 63,25, H 5,79, N 7,90.
Berechnet (%): C 63,58, H 6,19, N 6,45;
Gefunden (%): C 63,67, H 6,25, N 6,58.
Berechnet (%): C 63,32, H 5,87, N 7,78;
Gefunden (%): C 63,26, H 5,75, N 7,91.
Berechnet (%): C 63,32, H 5,87, N 7,78;
Gefunden (%): C 63,27, H 5,77, N 7,92.
Natrium-9-fluoro-8-(4-hydroxy-1-piperidyl)-5-methyl-6,7-dihydro-1-oxo-1H,5H-benzo[ÿ]chinolizin-2-karbonsäure|200 mg | |
Glukose | 250 mg |
destilliertes Wasser für Injektionen bis auf | 50 ml |
Natrium-9-fluoro-8-(4-hydroxy-1-piperidyl)-5-methyl-6,7-dihydro-1-oxo-1H,5H-benzo[ÿ]chinolizin-2-karbonsäure|100 g | |
Avicel | 40 g |
Maisstärke | 30 g |
Magnesiumstearat | 2 g |
Hydroxypropylmethylcellulose | 10 g |
Polyethylenglykol 6000 (Molekulargewicht 6000) | 3 g |
Kastoröl | 40 g |
Methanol | 40 g |
Natrium-9-fluoro-8-(4-hydroxy-1-piperidyl)-5-methyl-6,7-dihydro-1-oxo-1H,5H-benzo[ÿ]chinolizin-2-carboxylat|2 g | |
gereinigtes wäßriges Lanolin | 5 g |
Japanwachs | 5 g |
Vaseline | 88 g |
Natrium-9-fluoro-8-(morpholino-5-methyl-1-oxo-1H,5H-benzo[ÿ]chinolizin-2-carboxylat|100 g | |
Avicel | 40 g |
Maisstärke | 30 g |
Magnesiumstearat | 2 g |
Hydroxypropylmethylcellulose | 10 g |
Polyethylenglykol 6000 (Molekulargewicht 6000) | 3 g |
Kastoröl | 40 g |
Methanol | 40 g |
Natrium-9-fluoro-(3,5-dimethyl-1-piperazinyl)-5-methyl-6,7-dihydro-1-oxo-1H,5H-benzo[ÿ]chinolizin-2-carboxylat|100 g | |
Avicel | 40 g |
Maisstärke | 30 g |
Magnesiumstearat | 2 g |
Hydroxypropylmethylcellulose | 10 g |
Polyethylenglykol 6000 (Molekulargewicht 6000) | 3 g |
Kastoröl | 40 g |
Methanol | 40 g |
Natrium-9-fluoro-8-(morpholino-5-methyl-1-oxo-1H,5H-benzo[ÿ]chinolizin-2-carboxylat|200 mg | |
Glukose | 250 mg |
destilliertes Wasser für Injektionen bis auf | 5 ml |
Claims (6)
R¹ eine C₁-C₆-Alkylgruppe,
R² ein Halogenatom,
R³ eine 1-Pyrrolidinylgruppe oder eine Gruppe der Formel worin
R⁴ ein Wasserstoffatom, eine C₁-C₆-Alkylgruppe, eine C₁-C₆-Alkoxygruppe, eine Hydroxygruppe, eine C₁-C₆-Alkanoyloxygruppe, eine Aminogruppe, die mit einer C₁-C₆-Alkylgruppe oder einer C₁-C₆-Alkanoylgruppe substituiert sein kann, oder eine Oxogruppe bedeutet,
Z ein Sauerstoffatom, ein Schwefelatom oder eine Methylengruppe bedeutet und
m 1 oder 2 ist.
- a) eine Verbindung der Formel (II)
worin
R¹, R² die im Anspruch 1 genannten Bedeutungen haben und
X¹ ein Halogenatom, eine Niedrigalkansulfonyloxygruppe oder eine Arylsulfonyloxygruppe bedeutet,
mit einer Verbindung der allgemeinen FormelR³H (III)worin R³ die im Anspruch 1 festgelegten Bedeutungen hat, umsetzt, oder - b) eine Verbindung der Formel (V) worin R¹, R² und R³ die im Anspruch 1 genannten Bedeutungen haben, mit einer Verbindung der allgemeinen Formel (VI) worin R⁶, R⁷ und R⁸ eine C₁-C₆-Alkylgruppe bedeuten, oder einer Verbindung der allgemeinen Formel (VII)R⁹OCH=C(COOR¹⁰)₂ (VII)worin R⁹ und R¹⁰ jeweils eine C₁-C₆-Alkylgruppe bedeuten, umsetzt und die erhaltene Verbindung einer Zyklisierungsreaktion und gegebenenfalls einer Hydrolyse unterwirft, oder
- c) eine Verbindung der allgemeinen Formel (Ib)
worin
R¹, R² und R³ die in Anspruch 1 angegebenen Bedeutungen haben,
R¹¹ und R¹² jeweils ein Wasserstoffatom oder eine C₁-C₆-Alkylgruppe ist,
Y einen aromatischen heterozyklischen Ring, enthaltend ein tertiäres Stickstoffatom, über welches es gebunden ist, oder eine Alkylaminogruppe bedeutet, und
Z ein Anion ist, hydrolysiert.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP55158652A JPS5781486A (en) | 1980-11-10 | 1980-11-10 | Benzo(ij)quinolidine-2-carboxylic acid derivative |
JP56063170A JPS57176987A (en) | 1981-04-24 | 1981-04-24 | Pyrrolo(3,2,1-ij)quinoline-5-carboxylic acid derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3144455A1 DE3144455A1 (de) | 1982-06-24 |
DE3144455C2 true DE3144455C2 (de) | 1990-10-04 |
Family
ID=26404260
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19813144455 Granted DE3144455A1 (de) | 1980-11-10 | 1981-11-09 | Benzoheterozyklische verbindungen, verfahren zu deren herstellung und bakteriostatische mittel, welche diese enthalten |
DE2000175035 Active DE10075035I2 (de) | 1980-11-10 | 1981-11-09 | Benzo¬ij¾chinolizinderivate Verfahren zu deren Herstellung und bakteriostatische Mittel welche diese enthalten |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2000175035 Active DE10075035I2 (de) | 1980-11-10 | 1981-11-09 | Benzo¬ij¾chinolizinderivate Verfahren zu deren Herstellung und bakteriostatische Mittel welche diese enthalten |
Country Status (19)
Country | Link |
---|---|
US (2) | US4399134A (de) |
KR (1) | KR880001625B1 (de) |
AT (2) | AT395150B (de) |
AU (1) | AU546358B2 (de) |
CA (1) | CA1179341A (de) |
CH (1) | CH648845A5 (de) |
DE (2) | DE3144455A1 (de) |
DK (1) | DK160940C (de) |
ES (2) | ES507493A0 (de) |
FI (1) | FI71141C (de) |
FR (1) | FR2493849A1 (de) |
GB (1) | GB2086905B (de) |
IT (1) | IT1171646B (de) |
NL (1) | NL193457C (de) |
NO (1) | NO156828C (de) |
PH (1) | PH16685A (de) |
PT (1) | PT73957B (de) |
SE (1) | SE448542B (de) |
SU (2) | SU1366055A3 (de) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO156828C (no) * | 1980-11-10 | 1987-12-02 | Otsuka Pharma Co Ltd | Analogifremgangsm te for fremstilling av antibakterielt virksomme benzoheterocykliske forbindelser. |
US4380543A (en) * | 1981-11-06 | 1983-04-19 | Riker Laboratories, Inc. | Antimicrobial 8-cyano-6,7-dihydro-5-methyl-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acids |
PH22140A (en) * | 1982-06-29 | 1988-06-01 | Daiichi Seiyaku Co | Tricyclic compounds |
US4443447A (en) * | 1982-10-25 | 1984-04-17 | Riker Laboratories, Inc. | Phenyl-substituted tricyclic antibacterial agents |
JPS5978189A (ja) * | 1982-10-26 | 1984-05-04 | Otsuka Pharmaceut Co Ltd | ピロロ〔3,2,1−ij〕キノリン−5−カルボン酸誘導体 |
US4472406A (en) * | 1982-11-12 | 1984-09-18 | Riker Laboratories, Inc. | Antimicrobial 6,7-dihydro-8-(imidazol-1-yl)-5-methyl-1-oxo-1H,5H-benzo [ij]quinolizine-2-carboxylic acids and derivatives |
JPS59137482A (ja) * | 1983-01-26 | 1984-08-07 | Otsuka Pharmaceut Co Ltd | ピロロ〔3,2,1,−ij〕キノリン−5−カルボン酸誘導体 |
JPS59155381A (ja) * | 1983-02-22 | 1984-09-04 | Kyorin Pharmaceut Co Ltd | ベンゾキノリジンカルボン酸誘導体及びその製造法 |
US4473568A (en) * | 1983-03-01 | 1984-09-25 | Warner Lambert Company | Antibacterial thiazolidine or thiomorpholine substituted quinolines |
US4472407A (en) * | 1983-03-17 | 1984-09-18 | Riker Laboratories, Inc. | Antimicrobial 8-alkoxy-6,7-dihydro-5-methyl-9-fluoro-1-oxo-1H,5H-benzo[ij]qu |
US4562195A (en) * | 1984-02-02 | 1985-12-31 | Warner-Lambert Company | Reversing amnesia with saturated tricyclic nitrogen-containing diones |
US4571396A (en) * | 1984-04-16 | 1986-02-18 | Warner-Lambert Company | Antibacterial agents |
US4550103A (en) * | 1984-07-20 | 1985-10-29 | Warner-Lambert Company | Antibacterial 1-oxo-benzoquinolizine-2-carboxylic acids |
CA1253154A (en) * | 1985-05-24 | 1989-04-25 | Atsushi Takagi | Benzo¬ij|quinolizine-2-carboxylic acid derivatives |
US5210193A (en) * | 1986-01-17 | 1993-05-11 | American Cyanamid Company | Piperazine derivatives |
US4940710A (en) * | 1986-01-17 | 1990-07-10 | American Cyanamid Company | 7-(substituted)piperazinyl-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids |
US4948894A (en) * | 1989-02-21 | 1990-08-14 | American Cyanamid Company | 8-fluoro and 7, 8, 10-trifluoro-9-(substituted)-6-oxo-6H-benzo-(C)quinolizine-5-carboxylic acids |
KR900014383A (ko) * | 1989-03-29 | 1990-10-23 | 원본미기재 | 피롤로퀴놀린 유도체, 이의 제조방법 및 이를 사용한 항균제 |
DK0688218T3 (da) * | 1993-03-10 | 2000-03-13 | Otsuka Pharma Co Ltd | Interleukin-1-inhibitor |
US6034100A (en) * | 1993-03-10 | 2000-03-07 | Otsuka Pharmaceutical Co., Ltd. | Method for inhibiting cytokine secretion |
EP0908181B8 (de) * | 1996-05-20 | 2009-04-15 | Otsuka Pharmaceutical Co., Ltd. | Heilmittel fuer rosazea |
DE19718065A1 (de) * | 1997-04-29 | 1998-11-05 | Henkel Kgaa | Reinigungsmittel für nachvernetzende Polyurethan-Hotmelts |
ATE415969T1 (de) * | 1999-05-07 | 2008-12-15 | Wockhardt Ltd | (s)-benzochinolizincarbonsäuren und ihre verwendung als antibakterielle mittel |
US6750224B1 (en) | 1999-05-07 | 2004-06-15 | Wockhardt Limited | Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatment |
US6514986B2 (en) | 2000-11-22 | 2003-02-04 | Wockhardt Limited | Chiral fluoroquinolone arginine salt forms |
DE19962470A1 (de) * | 1999-12-22 | 2001-07-12 | Schulz Hans Herrmann | Verwendung von Chemotherapeutika |
DE60131416T2 (de) * | 2000-05-08 | 2008-09-18 | Wockhardt Ltd. | Chirale fluochinolon-argininsalzformen |
AU7866701A (en) * | 2000-05-08 | 2001-11-20 | Shiv Kumar Agarwal | Antibacterial chiral 8-(substituted piperidino)-benzo (i, j) quinolizines, processes, compositions and methods of treatment |
US6608078B2 (en) * | 2000-05-08 | 2003-08-19 | Wockhardt Limited | Antibacterial chiral 8-(substituted piperidino)-benzo [i,j] quinolizines, processes, compositions and methods of treatment |
US7098219B2 (en) | 2000-08-01 | 2006-08-29 | Wockhart Limited | Inhibitors of cellular efflux pumps of microbes |
US6878713B2 (en) | 2001-04-25 | 2005-04-12 | Wockhardt Limited | Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
US6964966B2 (en) * | 2001-04-25 | 2005-11-15 | Wockhardt Limited | Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
WO2003050107A1 (en) * | 2001-12-13 | 2003-06-19 | Wockhardt Limited | New generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
US6664267B1 (en) * | 2002-05-28 | 2003-12-16 | Wockhardt Limited | Crystalline fluoroquinolone arginine salt form |
EP1918289A3 (de) | 2002-05-28 | 2009-08-19 | Wockhardt Limited | Kristalline Form eines Fluorchinolon-Argininsalzes |
WO2004058303A2 (en) * | 2002-12-31 | 2004-07-15 | Wockhardt Limited | Compositions of benzoquinolizine carboxylic acid antibiotic drugs |
CA2512190A1 (en) * | 2002-12-31 | 2004-07-15 | Wockhardt Limited | Benzoquinolizine-2-carboxylic acid-containing compositions |
KR20120030558A (ko) * | 2003-09-04 | 2012-03-28 | 욱크하트 리미티드 | 벤조퀴놀리진-2-카복실산 아르기닌 염 사수화물 |
EA200801128A1 (ru) * | 2005-10-21 | 2008-10-30 | Глэксо Груп Лимитед | Пери-конденсированные трициклические соединения, полезные в качестве антибактериальных средств |
JP6240063B2 (ja) | 2011-04-28 | 2017-11-29 | ザ ブロード インスティテュート, インコーポレイテッド | ヒストンデアセチラーゼ阻害剤 |
JP6337255B2 (ja) | 2012-07-27 | 2018-06-06 | ザ ブロード インスティテュート, インコーポレーテッドThe Broad Institute, Inc. | ヒストンデアセチラーゼの阻害剤 |
WO2014100438A1 (en) | 2012-12-20 | 2014-06-26 | The Broad Institute, Inc. | Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors |
WO2015057659A1 (en) | 2013-10-14 | 2015-04-23 | Eisai R&D Management Co., Ltd. | Selectively substituted quinoline compounds |
EP3057948B1 (de) | 2013-10-14 | 2018-03-14 | Eisai R&D Management Co., Ltd. | Selektiv substituierte chinolinderivate |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE793524A (fr) * | 1971-12-30 | 1973-06-29 | Riker Laboratories Inc | Acides benzoquinolizine-carboxyliques et leurs derives |
US4001243A (en) * | 1972-11-02 | 1977-01-04 | Riker Laboratories, Inc. | Substituted benzo(ij)quinolizine-2-carboxylic acids and derivatives thereof |
US3917609A (en) * | 1973-06-27 | 1975-11-04 | Minnesota Mining & Mfg | Pyrroloquinoline carboxylic acids and derivatives |
JPS6019910B2 (ja) * | 1979-10-11 | 1985-05-18 | 大塚製薬株式会社 | ベンゾ〔ij〕キノリジン−2−カルボン酸誘導体及びその製造法 |
DE2953974C2 (de) * | 1978-04-12 | 1992-06-25 | Otsuka Pharmaceutical Co., Ltd., Tokio/Tokyo, Jp | |
US4416884A (en) * | 1978-04-12 | 1983-11-22 | Otsuka Pharmaceutical Co., Ltd. | Piperazinylbenzoheterocyclic compounds |
JPS5540616A (en) * | 1978-09-14 | 1980-03-22 | Otsuka Pharmaceut Co Ltd | Preparation of benzo-hetero-compound |
JPS5630964A (en) * | 1979-08-22 | 1981-03-28 | Kyorin Pharmaceut Co Ltd | Novel substituted quinolinecarboxylic acid and its preparation |
JPS55149284A (en) * | 1980-05-02 | 1980-11-20 | Otsuka Pharmaceut Co Ltd | Piperazinylbenzo heterocyclic derivative |
NO156828C (no) * | 1980-11-10 | 1987-12-02 | Otsuka Pharma Co Ltd | Analogifremgangsm te for fremstilling av antibakterielt virksomme benzoheterocykliske forbindelser. |
AT380250B (de) * | 1980-12-18 | 1986-04-25 | Otsuka Pharma Co Ltd | Verfahren zur herstellung benzoheterocyclischer verbindungen |
-
1981
- 1981-11-04 NO NO813726A patent/NO156828C/no not_active IP Right Cessation
- 1981-11-05 AT AT0474881A patent/AT395150B/de not_active IP Right Cessation
- 1981-11-09 DK DK495281A patent/DK160940C/da not_active IP Right Cessation
- 1981-11-09 FI FI813526A patent/FI71141C/fi not_active IP Right Cessation
- 1981-11-09 DE DE19813144455 patent/DE3144455A1/de active Granted
- 1981-11-09 PT PT73957A patent/PT73957B/pt unknown
- 1981-11-09 IT IT49656/81A patent/IT1171646B/it active
- 1981-11-09 SU SU813354800A patent/SU1366055A3/ru active
- 1981-11-09 DE DE2000175035 patent/DE10075035I2/de active Active
- 1981-11-09 SE SE8106642A patent/SE448542B/sv unknown
- 1981-11-10 CH CH7200/81A patent/CH648845A5/de not_active IP Right Cessation
- 1981-11-10 KR KR1019810004344A patent/KR880001625B1/ko active
- 1981-11-10 NL NL8105075A patent/NL193457C/nl not_active IP Right Cessation
- 1981-11-10 US US06/320,027 patent/US4399134A/en not_active Expired - Lifetime
- 1981-11-10 ES ES507493A patent/ES507493A0/es active Granted
- 1981-11-10 CA CA000389769A patent/CA1179341A/en not_active Expired
- 1981-11-10 GB GB8133890A patent/GB2086905B/en not_active Expired
- 1981-11-10 PH PH26477A patent/PH16685A/en unknown
- 1981-11-10 AU AU77335/81A patent/AU546358B2/en not_active Expired
- 1981-11-10 FR FR8121100A patent/FR2493849A1/fr active Granted
-
1982
- 1982-10-15 ES ES516523A patent/ES8401035A1/es not_active Expired
- 1982-12-27 SU SU823527501A patent/SU1277896A3/ru active
-
1983
- 1983-05-25 US US06/497,914 patent/US4552879A/en not_active Expired - Lifetime
-
1989
- 1989-12-20 AT AT2887/89A patent/AT393383B/de not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3144455C2 (de) | ||
DE69434380T2 (de) | Pyridazino-Chinolin Verbindungen | |
DE3514076C2 (de) | ||
EP0259804B1 (de) | Pyrido [3,2,1-ij]-1,3,4-benzoxadiazinderivate, Verfahren zu deren Herstellung, entsprechende pharmazeutische Präparate und im Verfahren verwendbare Zwischenprodukte | |
DD155990A5 (de) | Verfahren zur herstellung von 1,8-naphthyridin-verbindungen | |
EP0528922B1 (de) | Neue sulfonylverbindungen | |
DD145753A5 (de) | Verfahren zur herstellung von naphthyridinderivaten | |
DE69823493T2 (de) | Tetrahydropyridoverbindungen | |
EP0187376B1 (de) | 6,7-Disubstituierte 1-Cyclopropyl-1,4-dihydro-4-oxo-1,8-naphthyridin-3-carbonsäuren | |
EP0205029A2 (de) | Antibakteriell wirksame Chinoloncarbonsäureester | |
DE2914258C2 (de) | ||
EP0217372A2 (de) | Neue polyoxygenierte Labdan-Derivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Medikamente | |
DE3601567A1 (de) | 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate | |
DE3037103C2 (de) | ||
DE3153221C2 (de) | ||
DE3542002A1 (de) | 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel | |
DE60037587T2 (de) | Optisch aktive quinolin-carbonsäure-derivate mit einem 7-pyrrolidin-substituenten, der die optische aktivität verursacht und ein verfahren zu seiner herstellung | |
EP0589318B1 (de) | Antibakterielle 7-(Aminomethyl-oxa-7-aza-bicyclo 3.3.0 oct-7-yl)chinolon- und -naphthyridoncarbonsäure-Derivate | |
SU1407399A3 (ru) | Способ получени производных пиперазинилбензогетероциклических соединений или их фармацевтически приемлемых солей | |
EP0653425A1 (de) | 1-(2-Fluorcyclopropyl)-chinolon- und naphthyridoncarbonsäure-Derivate, deren Herstellung und deren Verwendung in antibakteriellen Mitteln | |
EP0726270B1 (de) | 1,6-Naphthyridoncarbonsäurederivate | |
CH642081A5 (de) | Derivate der beta-lactamserie und diese enthaltende pharmazeutische zubereitungen. | |
JPH037674B2 (de) | ||
DE2459955A1 (de) | Neue vinylderivate mit antibakterieller aktivitaet sowie verfahren zu deren herstellung | |
CH638808A5 (de) | Pyrido(3,2,1-jk)carbazol-derivate. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OP8 | Request for examination as to paragraph 44 patent law | ||
8172 | Supplementary division/partition in: |
Ref document number: 3153221 Country of ref document: DE |
|
Q171 | Divided out to: |
Ref document number: 3153221 Country of ref document: DE |
|
8125 | Change of the main classification |
Ipc: C07D455/04 |
|
AH | Division in |
Ref document number: 3153221 Country of ref document: DE |
|
D2 | Grant after examination | ||
8364 | No opposition during term of opposition | ||
AH | Division in |
Ref document number: 3153221 Country of ref document: DE |
|
V448 | Application of spc |
Free format text: PRODUCT NAME: NADIFLOXACIN; REGISTRATION NO/DATE: 44621.00.00, 20000706 Spc suppl protection certif: 100 75 035 Filing date: 20001206 |
|
V457 | Spc granted |
Free format text: PRODUCT NAME: NADIFLOXACIN; REGISTRATION NO/DATE: 44621.00.00, 20000706 Spc suppl protection certif: 100 75 035 Filing date: 20001206 |
|
V464 | Spc expired |
Free format text: PRODUCT NAME: NADIFLOXACIN; REGISTRATION NO/DATE: 44621.00.00, 20000706 Spc suppl protection certif: 100 75 035 Filing date: 20001206 |